Evidence map›Paper›PMID 37934343›Full record

ArticleInternal and emergency medicine2024

A global analysis of implants and replacements of pacemakers and cardioverter-defibrillators before, during, and after the COVID-19 pandemic in Italy.

Massimo Zecchin, Enrico Ciminello, Veronica Mari, Alessandro Proclemer, Antonio D'Onofrio, Gabriele Zanotto, Roberto De Ponti, Teresa Maria Capovilla, Paola Laricchiuta, Alessia Biondi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Internal and emergency medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Massimo Zecchin *Cardiothoracovascular Department, Cattinara Hospital, ASUGI and University of Trieste, Trieste, Italy.
Enrico Ciminello *Italian National Institute of Health, Rome, Italy.
Veronica MariItalian National Institute of Health, Rome, Italy.
Alessandro ProclemerHospital Santa Maria Della Misericordia, Udine, Italy.
Antonio D'OnofrioMonaldi Hospital, Naples, Italy.
Gabriele ZanottoMagalini Hospital, Villafranca Di Verona, Italy.
Roberto De PontiUniversity of Insubria, Varese, Italy.
Teresa Maria CapovillaCardiothoracovascular Department, Cattinara Hospital, ASUGI and University of Trieste, Trieste, Italy.
Paola LaricchiutaItalian National Institute of Health, Rome, Italy.
Alessia BiondiItalian National Institute of Health, Rome, Italy.
Letizia SampaoloItalian National Institute of Health, Rome, Italy.
Simona PascucciItalian National Institute of Health, Rome, Italy.
Gianfranco SinagraCardiothoracovascular Department, Cattinara Hospital, ASUGI and University of Trieste, Trieste, Italy.
Giuseppe BorianiCardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. giuseppe.boriani@unimore.it.ORCID 0000-0002-9820-4815
Eugenio CarraniItalian National Institute of Health, Rome, Italy.
Marina TorreItalian National Institute of Health, Rome, Italy.
University of Trieste · ITOspedale Monaldi · ITOspedale Santa Maria della Misericordia di Udine · ITUniversity of Insubria · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the beginning of the COVID-19 emergency, non-urgent surgical procedures had to be deferred, but also emergencies were reduced. To assess the global trend of pacemaker (PM) and implantable cardiac-defibrillator (ICD) procedures performed in Italy before, during, and after the first COVID-19 emergency, all the Italian hospital discharge records related to PM/ICD procedures performed between 2012 and 2021, sent to the National Institute of Health, were reviewed. Compared to 2019, in 2020, there was a reduction of first PM implants (52,216 to 43,962, -16%; p < 0.01), but not replacements (16,591 to 17,331, + 4%; p = 0.16). In particular, in April 2020, there was a drop of first implants (- 53,4% vs the average value of April 2018 and April 2019; p < 0.01), while the reduction of replacements was less evident (-32.6%; p = NS). In 2021, PM procedures increased to values similar to the pre-pandemic period. A reduction of ICD procedures was observed in 2020 (22,355, -7% toward 2019), mainly in April 2020 (- 46% vs April 2018/April 2019; p = 0.03). In 2021, the rate of ICD procedures increased (+ 14% toward 2020). A non-significant reduction of "urgent" procedures (complete atrioventricular block for PM and ventricular fibrillation for ICD), even in April 2020, was observed. In 2020, there was a reduction of first PM implants and ICDs, offset by increased activity in 2021. No decrease in PM replacements was observed, and the drop in "urgent" PM and ICD procedures was not statistically significant.

Indexed as

COVID-19Defibrillators, ImplantablePacemaker, ArtificialHumansItalyPandemicsRegistriesCOVID-19 pandemicHospital discharge recordsImplantable cardioverter-defibrillatorLockdownPacemakerReplacement

Identifiers

PMID37934343
PMCPMC10827813
OpenAlexW4388446706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.